FI972170A0 - Peptider vilka är kapabla att binda sig vid GAP-protein SH3-domen, dessa peptider kodande nukleotidsekvenser, framställning och användning av dem - Google Patents

Peptider vilka är kapabla att binda sig vid GAP-protein SH3-domen, dessa peptider kodande nukleotidsekvenser, framställning och användning av dem

Info

Publication number
FI972170A0
FI972170A0 FI972170A FI972170A FI972170A0 FI 972170 A0 FI972170 A0 FI 972170A0 FI 972170 A FI972170 A FI 972170A FI 972170 A FI972170 A FI 972170A FI 972170 A0 FI972170 A0 FI 972170A0
Authority
FI
Finland
Prior art keywords
peptides
domain
binding
preparing
nucleotide sequences
Prior art date
Application number
FI972170A
Other languages
English (en)
Finnish (fi)
Other versions
FI972170A (sv
Inventor
Marc Duchesne
Didier Faucher
Fabienne Parker
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9413955A external-priority patent/FR2727116B1/fr
Priority claimed from FR9505753A external-priority patent/FR2734266B1/fr
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI972170A publication Critical patent/FI972170A/sv
Publication of FI972170A0 publication Critical patent/FI972170A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI972170A 1994-11-22 1997-05-21 Peptider vilka är kapabla att binda sig vid GAP-protein SH3-domen, dessa peptider kodande nukleotidsekvenser, framställning och användning av dem FI972170A0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9413955A FR2727116B1 (fr) 1994-11-22 1994-11-22 Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR9505753A FR2734266B1 (fr) 1995-05-16 1995-05-16 Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
PCT/FR1995/001539 WO1996016169A1 (fr) 1994-11-22 1995-11-22 Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation

Publications (2)

Publication Number Publication Date
FI972170A FI972170A (sv) 1997-05-21
FI972170A0 true FI972170A0 (sv) 1997-05-21

Family

ID=26231549

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972170A FI972170A0 (sv) 1994-11-22 1997-05-21 Peptider vilka är kapabla att binda sig vid GAP-protein SH3-domen, dessa peptider kodande nukleotidsekvenser, framställning och användning av dem

Country Status (18)

Country Link
US (1) US5886150A (sv)
EP (1) EP0793721B1 (sv)
JP (2) JPH10509044A (sv)
AT (1) ATE305037T1 (sv)
AU (1) AU713937B2 (sv)
BR (1) BR9510067A (sv)
CA (1) CA2204438A1 (sv)
CZ (1) CZ292538B6 (sv)
DE (1) DE69534471T2 (sv)
DK (1) DK0793721T3 (sv)
ES (1) ES2248800T3 (sv)
FI (1) FI972170A0 (sv)
HU (1) HU221410B1 (sv)
IL (1) IL116026A (sv)
MX (1) MX9703364A (sv)
NO (1) NO972313L (sv)
SK (1) SK287034B6 (sv)
WO (1) WO1996016169A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780062B1 (fr) * 1998-06-17 2000-07-28 Rhone Poulenc Rorer Sa Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
AU773891C (en) * 1998-10-23 2005-02-17 Kirin-Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
WO2001096873A2 (en) * 2000-06-16 2001-12-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying apoptosis-modified proteins
US7846746B2 (en) * 2001-04-10 2010-12-07 Children's Medical Center Corporation Methods of analysis and labeling of protein-protein interactions
WO2003006060A1 (fr) * 2001-07-09 2003-01-23 Kyowa Hakko Kogyo Co., Ltd. Inhibiteurs de la liaison au domaine sh3
US20050069999A1 (en) * 2001-07-09 2005-03-31 Sharma Sreenath V Sh3 domain binding inhibitors
AUPR721101A0 (en) * 2001-08-23 2001-09-13 University Of Queensland, The Nucleic acid and polypeptide linked to breast cancer
MX2007000216A (es) * 2004-07-08 2007-03-15 Amgen Inc Peptidos terapeuticos.
EA011879B1 (ru) * 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
US11237168B2 (en) * 2019-06-26 2022-02-01 St. Jude Children's Research Hospital Method for identifying modulators of G3BP activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
AU652724B2 (en) * 1989-08-21 1994-09-08 Chiron Corporation Peptides from GTPase-activating protein (GAP) and diagnostic and therapeutic use thereof
EP0496162A3 (en) * 1990-12-24 1993-09-01 Merck & Co. Inc. Peptide inhibitors of ras-gap interaction
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
AU6083894A (en) * 1993-01-15 1994-08-15 Schering Corporation Ras associated gap proteins

Also Published As

Publication number Publication date
MX9703364A (es) 1997-08-30
US5886150A (en) 1999-03-23
BR9510067A (pt) 1997-12-30
ATE305037T1 (de) 2005-10-15
AU713937B2 (en) 1999-12-16
CZ154597A3 (en) 1997-10-15
CZ292538B6 (cs) 2003-10-15
NO972313D0 (no) 1997-05-21
IL116026A0 (en) 1996-01-31
WO1996016169A1 (fr) 1996-05-30
FI972170A (sv) 1997-05-21
DK0793721T3 (da) 2006-01-30
HUT77029A (hu) 1998-03-02
EP0793721B1 (fr) 2005-09-21
JP2006122049A (ja) 2006-05-18
NO972313L (no) 1997-05-21
SK62997A3 (en) 1998-02-04
HU221410B1 (en) 2002-09-28
AU4263696A (en) 1996-06-17
ES2248800T3 (es) 2006-03-16
DE69534471D1 (de) 2006-02-02
EP0793721A1 (fr) 1997-09-10
IL116026A (en) 2005-08-31
JPH10509044A (ja) 1998-09-08
CA2204438A1 (fr) 1996-05-30
SK287034B6 (sk) 2009-10-07
DE69534471T2 (de) 2006-06-22

Similar Documents

Publication Publication Date Title
FI953442A0 (sv) Frystorkade kulor innehållande gonadotropin
FI972170A0 (sv) Peptider vilka är kapabla att binda sig vid GAP-protein SH3-domen, dessa peptider kodande nukleotidsekvenser, framställning och användning av dem
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
FI962247A (sv) Nya apoptosmodulerande proteiner, DNA vilket kodar dessa proteiner samt förfarande för användning av dessa
FR2690162B1 (fr) Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.
SE9801455D0 (sv) New receptor
FI961202A0 (sv) Grb3-3-gen, dess varianter och deras användningar
MX9806041A (es) Proteina purificada sr-p70.
DE59503539D1 (de) Katalysator zur herstellung und verarbeitung von polyorganosiloxanen
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
PT1141305E (pt) Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
SE9602822D0 (sv) New receptor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ZA982009B (en) Isolated nucleic acid molecules encoding SSX family members and uses thereof.
AU6722498A (en) Disubstituted biphenyloxazolines
DE69529235D1 (de) Menschliche dnase i varianten
SE9604439D0 (sv) New receptor
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

FC Application refused
RF Appeal filed
FD Application lapsed